Cargando…
Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: Results of two prospective trials
BACKGROUND. To assess genitourinary (GU) function and toxicity in patients treated with image-guided proton therapy (PT) for early- and intermediate-risk prostate cancer and to analyze the impact of pretreatment urinary obstructive symptoms on urinary function after PT. MATERIAL AND METHODS. Two pro...
Autores principales: | Henderson, Randal H., Hoppe, Bradford S., Marcus, Robert B., Mendenhall, William M., Nichols, R. Charles, Li, Zuofeng, Su, Zhong, Morris, Christopher G., Williams, Christopher R., Costa, Joseph, Mendenhall, Nancy P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603169/ https://www.ncbi.nlm.nih.gov/pubmed/23477359 http://dx.doi.org/10.3109/0284186X.2013.764467 |
Ejemplares similares
-
Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression
por: Kil, Whoon Jong, et al.
Publicado: (2013) -
Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?
por: Bryant, Curtis, et al.
Publicado: (2016) -
Erectile Function, Incontinence, and Other Quality of Life Outcomes Following Proton Therapy for Prostate Cancer in Men 60 Years Old and Younger
por: Hoppe, Bradford S, et al.
Publicado: (2012) -
Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical Prostatectomy
por: Kharod, Shivam M., et al.
Publicado: (2021) -
Proton therapy in the management of non-Hodgkin lymphoma
por: Sachsman, Suzanne, et al.
Publicado: (2015)